ANG Lifesciences India reports consolidated net loss of Rs 2.06 crore in the March 2025 quarter
Net Loss of ANG Lifesciences India reported to Rs 2.06 crore in the quarter ended March 2025 as against net loss of Rs 3.65 crore during the previous quarter ended March 2024. Sales declined 55.55% to Rs 16.82 crore in the quarter ended March 2025 as against Rs 37.84 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 12.41 crore in the year ended March 2025 as against net loss of Rs 10.14 crore during the previous year ended March 2024. Sales declined 36.45% to Rs 92.85 crore in the year ended March 2025 as against Rs 146.11 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 16.82 | 37.84 | -56 | 92.85 | 146.11 | -36 |
| OPM % | -4.16 | 8.88 | - | -2.44 | 6.61 | - |
| PBDT | -2.47 | -0.29 | -752 | -8.94 | -0.60 | -1390 |
| PBT | -3.89 | -2.34 | -66 | -15.70 | -8.97 | -75 |
| NP | -2.06 | -3.65 | 44 | -12.41 | -10.14 | -22 |